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Background: Effective means are needed to efficiently collect fecal samples for microbiome analysis in large-scale
epidemiological studies. Using twenty-four fecal aliquots prepared from three healthy individuals, we compared the
following four fecal sample collection methods for assessment of human gut microbiome: 1) fecal occult blood
test cards, held at room temperature for three days, 2) Eppendorf tubes, at room temperature for three days,
3) Eppendorf tubes with RNAlater, at room temperature, and 4) as controls, samples immediately frozen at −80°C.
The 24 samples were assayed by 16S rRNA gene sequencing to compare overall microbiome structure and taxon
distributions according to collection method.
Results: Storing fecal occult blood test card samples at room temperature for three days did not affect total DNA
purity and relative 16S rRNA bacterial gene contents, compared with fresh frozen collection. Overall microbiome
structure, based on phylogenetic UniFrac index, differed significantly by subject (p = 0.001), but microbiome
structure (p = 0.497) and relative abundance of major microbial taxa (phyla) (p > 0.05) did not differ significantly by
collection method.
Conclusions: Our findings suggest that low-cost fecal occult blood test card collection may be a feasible means of
sample collection for fecal microbiome assessment in large-scale population-based studies.
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The human bowel hosts trillions of gut microbial cells,
the gut microbiome [1]. Although case–control investi-
gation points to a potential role of the gut microbiome
in colorectal cancer [2], large-scale prospective study of
this association has been impeded by the lack of validated
fecal sample collection methods suitable for large-scale
studies. Our interest was in development of a fecal sample
collection method that is accurate, while also being cost-
efficient and easy for the study participant to use. Because
fecal collections may take place outside of research clinics,
we also wished to develop a fecal collection approach
which would not require immediate sample processing.
To address this need, we evaluated the utility of the
Beckman Coulter Hemoccult Sensa® card (Beckman
Coulter, CA) for gut microbiome characterization because* Correspondence: Jiyoung.Ahn@nyumc.org
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article, unless otherwise stated.it offers a practical way to collect fecal samples for large-
scale study. As freezing at ultralow temperatures stabilizes
bacterial samples [3], we compared results for samples
collected by the card method to results for samples imme-
diately stored in Eppendorf tubes at −80°C [4]; we also in-
cluded storage in Eppendorf tubes at room temperature as
part of our evaluation. Finally, we were interested in evalu-
ating the utility of collection in RNAlater, because this
RNA-stabilizing agent has been shown to be suitable for
samples dedicated for DNA amplification [5,6]. Our main
goal was to assess the effect the different storage condi-
tions have on gut microbiome diversity parameters in-
cluding overall diversity and specific taxon abundances
because different methods might differentially impact
bacterial overgrowth or DNA degradation that could
lead to biased assessment of these microbial parameters.
Methods
Study population and fecal biospecimen collection
Three healthy volunteers (2 females and 1 male) provided
fecal biospecimens at NYU Langone Medical Center, Newntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this





reads (Mean ± SD)d
Method 1: Card 1.86 ± 0.05 12,448 ± 8,761
Method 2: Room Temperature 1.81 ± 0.07 16,451 ± 12,004
Method 3: RNAlater 1.66 ± 0.14c 13,393 ± 5,909
Method 4: Frozen 1.80 ± 0.05 14,467 ± 10,030
a1: fecal occult blood test cards at room temperature for 3 days, 2: Eppendorf
tubes at room temperature for 3 days, 3: Eppendorf tubes with RNAlater at
room temperature for 3 days or 4: frozen at −80°C for 3 days.
bAnova was used to test for overall differences across storage methods
(p < 0.005).
cBased on Anova results, we conducted Post Hoc TEST (LSD method) to make
multiple comparisons, indicating that Method 3 resulted in lower OD 260/280
ratio (p < 0.05).
dKruskal-Wallis was used to test for overall differences across storage
methods (p = 0.84).
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quotted within 30 minutes of stool production, in duplicate
using the four following collection and storage methods.
In Method 1 (card) the fecal sample was smeared onto a
Beckman Coulter Hemoccult Sensa® card (Beckman
Coulter, CA) and kept at room temperature. In Method
2 (room temperature) fecal samples were placed in an
Eppendorf tube and left at room temperature. In
Method 3 (RNAlater) fecal samples were placed in an
Eppendorf tube containing 1 ml RNAlater Solution®
(Life technologies, NY) and left at room temperature. In
Method 4 (frozen) fecal samples were frozen on collec-
tion at −80°C in a 1.5 ml Eppendorf tube. All samples
were stored for three days in their respective method.
We chose three days to mimic the conditions of samples
being collected at home and returned to us by mail.
Ethics statements
The study protocol was approved by the NYU Langone
Medical Center Institutional Review Board. All study
participants provided informed consent.
16S rRNA microbiome assay
After three days of storage for the four methods, gen-
omic DNA was extracted from the 24 fecal aliquots
using the PowerLyzer PowerSoil DNA Isolation Kit (Mo
Bio Laboratory Inc. CA) following the manufacturer’s
protocol. DNA concentration was quantified using the
Synergy™ H1M microplate reader (Biotech, VM) and
corresponding OD 260/280 ratio was used to check
DNA purity. 16S rRNA gene amplicon libraries were
generated using primers incorporating FLX Titanium
adapters and a sample barcode sequence covering vari-
able region V3 to V4 as we described elsewhere [7]. The
amplicon library was sequenced using the 454 Roche
FLX Titanium pyrosequencing system following the
manufacturer’s instructions.
The QIIME pipeline [8] was used to process and filter
multiplexed sequence reads. The UCLUST method [9]
was used to cluster the filtered sequences with ≥97% simi-
larity into Operational Taxonomic Unit (OTUs). Chimeric
sequences were identified by ChimeraSlayer [10] and re-
moved. Representative sequences from each OTU were
assigned taxonomy using the Ribosomal Database Project
classifier method [11] and the IMG/GG GreenGenes data-
base of microbial genomes. A phylogenetic tree was con-
structed by applying the FastTree method [12] to the
representative sequences.
Rarefactions of 10 to 8,414 [minimum-maximum se-
quence depth] randomly selected sequences from each
sample were used to calculate the Shannon index, a
measure of within sample diversity, and to generate rar-
efaction plots. Pairwise comparisons of Shannon indices
by subject and storage condition were obtained byMonte Carlo permutation. All p-values were adjusted by
Bonferroni correction. To measure the diversity among
subjects or storage conditions, a single rarefaction was
performed at a sequencing depth of 4000 so that all
samples were included in analyses. Distance matrices
containing all pairwise comparisons were created for un-
weighted (presence/absence) dissimilarity values using
the UniFrac phylogenetic method [13]. Principal coordi-
nates were computed for the unweighted distance matri-
ces and used to generate Principal Coordinate Analysis
plots (PCoA). The non-parametric method, adonis [14],
was used to identify significant differences in phylogenetic
distance variation by subjects and by storage condition.
The Unweighted Pair Group Method with Arithmetic
Mean (UPGMA) for clustering of samples was also carried
out on the unweighted distance matrices [8]. A two-
sample t-test was used to test for differences between the
within and between group variances, with p-values ad-
justed by Bonferroni correction. Relative abundances of
the three major phyla (Bacteroidetes, Firmicutes, Actino-
bacteria) were compared for the four methods, using the
Mann–Whitney-Wilcoxon test, and compared by subject,
using the Kruskal-Wallis test (SAS, version 9.3, SAS Insti-
tute, Cary, NC).
Results
DNA from 24 fecal aliquots was successfully extracted
and amplified. The OD 260/280 ratio, a measure of DNA
purity, was greater than 1.8 in samples collected from
card, room temperature, and frozen methods; DNA purity
from these methods were higher than DNA purity from
RNAlater (Table 1, p < 0.05). From the initial 584,367
microbial 16S rRNA sequences, 347,795 sequence reads
passed filtering criteria. 16.6% of these sequences were
chimeric and subsequently removed resulting in 290,110
high-quality sequence reads (12,088 ± 7,302 [mean ± SD]
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The number of sequence reads did not differ significantly
according to collection methods (Table 1, p = 0.84).
Overall gut microbial diversity did not differ signifi-
cantly according to the four fecal sample collection
methods. The Shannon index, an indicator of gut micro-
bial diversity, did not significantly differ by room
temperature storage on either a fecal occult blood test
card or in an Eppendorf tube compared to frozen samples
(Figure 1, p = 0.696-1.00) but RNAlater samples tended to
be less diverse than frozen samples (p = 0.072). Principal
coordinate analysis based on unweighted UniFrac dis-
tances, a phylogeny-based distance metric, indicated that
samples clustered by subject (Figure 2A, p = 0.001), rather
than by storage condition (Figure 2B, p = 0.497). Hier-
archical clustering of unweighted UniFrac distances fur-
ther substantiated these findings (Figure 2C), revealing
three distinct clusters by subject and not by collection
method. Consistent with these findings, the gut micro-
bial community composition varied significantly less
within subjects than between subjects (Figure 2D, p =
2.89e-89). In contrast, the microbial community com-
position variation within collection methods was not
statistically different from the variation across collection
methods (p = 1.00).
Relative abundances of gut microbial taxa were not sta-
tistically different for any of the three test methods, when
compared to relative abundances from frozen samples.
The average relative abundances for the three major phyla
were Firmicutes (12.2%), Bacteroidetes (86.2%), andFigure 1 Alpha rarefaction plot of Shannon indices (±Standard
Error) according to collection method. Card (green), Room
Temperature (blue), RNAlater (orange), Frozen (red). Statistical
significance was tested by using non-parametric Monte Carlo
permutations (QIIME).Actinobacteria (0.7%). As shown in Figure 3, there was
variability in the relative abundance of phyla by subject
for Bacteroidetes (p = 0.003), Firmicutes (p = 0.0023),
and Actinobacteria (p = 0.0002). For Bacteroidetes, Fir-
micutes, and Actinobacteria, relative abundances from
samples stored in any one of the three unfrozen methods
were not statistically different from relative abundances
for samples immediately frozen (p > 0.05 for all).Discussion
We found no evidence of significant differences in gut mi-
crobial community composition and taxon distributions
for storage at room temperature on a fecal occult blood
test card or in an Eppendorf tube compared to immedi-
ately frozen samples. Not surprisingly, overall microbial
diversity varied by subject. We found a decrease in DNA
purity for samples collected with RNAlater.
Although the effect of collection container has not
been previously assessed, our general observation that
inter-individual differences in bacterial composition were
greater than the differences by collection method is
consistent with findings from previous studies. Multiple
studies have tested storage durations (up to six months)
and storage temperatures ranging from 20°C to −80°C;
most studies [4,15,16], though not all [17,18], have found
that these fecal collection methods did not significantly
influence the gut microbiome diversity and taxon distri-
bution. Two other studies reported that storage at −20°C
for up to 53 days influenced specific taxa, including
Bacteroidetes abundance [19] and the Firmicutes to Bac-
teroidetes ratio [20], however, we did not observe these
trends in our study.
Samples collected with RNAlater had significantly
lower DNA purity and tended to show lower microbial
diversity. RNAlater is used to stabilize and protect RNA
from degradation in tissue during long term storage and
has been shown to also be suitable for DNA preservation
[21]. However, we observed that fecal samples were very
hard to disperse evenly in RNAlater during processing
and that DNA purity was lower. Low-quality DNA can
interfere with downstream applications including PCR
amplification [22], a possible reason for the trend toward
reduced Shannon indices. Two studies showed that stor-
age in RNAlater is suitable for PCR amplification of bac-
terial DNA [5,6]. While the first study showed that total
DNA yields from RNAlater samples were higher com-
pared to refrigeration storage and liquid nitrogen freez-
ing, the impact on Shannon indices was not described
[5]. Using gorilla fecal samples, the second study re-
ported that DNA purity and Shannon indices were not
significantly different between RNAlater samples and
samples stored at −30°C [6]. RNAlater storage increases
the potential utility of stored fecal samples, so further
Figure 2 Unweighted PCoA plots of the first two principal coordinates. A), B) The first two principal coordinates were grouped by subject
(1 [red], 2 [blue], 3 [orange]) A) or collection method (card [green], room temperature [blue], RNAlater [orange], frozen [red]) B). Adonis was used
to test for significant differences in the variation in distances across subjects or collection methods using QIIME. C) UPGMA clustering on
unweighted UniFrac distances (subject 1 [red], 2 [blue], 3 [orange]). D) Mean (±Std) unweighted UniFrac distances within and between sample
collection methods or subjects.
Figure 3 Relative abundances of phyla by subject and by collection method. Card (1A-3A), Room Temperature (1B-3B), RNAlater (1C-3C),
Frozen (1D-3D). Kruskal-Wallis or Mann-Whitney-Wilcoxon tests were used to test for overall differences using SAS software (version 9.3).
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tion for which this reagent is suitable.
Although our study showed no differences in micro-
biome composition between card collection with room
temperature storage and collection in Eppendorf tube
with immediate freezing, we recognize that a larger series
of samples may have identified some differences not found
here. Also, our subjects were healthy and the collected
samples may not have captured the full range of stool con-
ditions that might be expected if subjects were ill. These
considerations may be important in carrying out stool col-
lection in different study settings.
Our findings support the use of fecal occult blood test
card collections for microbiome assessment of fecal sam-
ples. These cards are commercially available and inexpen-
sive. The small size and flat shape also makes the card
easier to include in packages to be sent to participants,
compared to bulkier Eppendorf tubes. Study subjects can
easily collect samples on the cards. Because the cards are
widely used in colorectal cancer screening [23], potential
participants might also be more accepting of collecting
samples in this way. A possible drawback of the Hemoc-
cult Sensa® card is that it contains a chemical reagent used
to detect blood in the stool [24] which could possibly
affect gut microbiome. However, we found no evidence of
a significant difference in gut microbiome in fecal samples
collected by this method. Findings that results were un-
affected by three-day storage at room temperature of the
collection cards or Eppendorf tubes suggests that partici-
pant home-collection and mailing of these samples is suit-
able for epidemiological studies.
Conclusions
Our findings suggest that fecal collection on a fecal oc-
cult blood test card or in an Eppendorf tube and storage
for three days at room temperature does not substantially
influence the assessment of gut microbiome. Because of
the low-cost and simplicity of use, fecal occult blood test
card collection may be a feasible method for large-scale
population-based studies.
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